Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above

Clinical trial NCT07285265 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07285265
Sponsor: Suzhou Abogen Biosciences Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Varicella-zoster Virus

Start date: 2025-05-27
Primary completion: 2025-11-06
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.